Prevalence and Impact of Co-morbidity Burden as Defined by the Charlson Co-morbidity Index on 30-Day and 1- and 5-Year Outcomes after Coronary Stent Implantation (from the Nobori-2 Study)

American Journal of Cardiology

Volumn 116, Issue 3, 2015, Pages 364-371

  Mamas, Mamas A ^a,b,c   Fath Ordoubadi, Farzin ^d   Danzi, Gian B ^e   Spaepen, Erik ^f   Kwok, Chun Shing ^c   Buchan, Iain ^a,b,c   Peek, Niels ^a,b,c   De Belder, Mark A ^g   Ludman, Peter F ^h   Paunovic, Dragica ⁱ   Urban, Philip ^j  

^a KEELE UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^e FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^f SBD Analytics   (Belgium)

^g JAMES COOK UNIVERSITY HOSPITAL   (United Kingdom)

^h QUEEN ELIZABETH HOSPITAL   (United Kingdom)

ⁱ Terumo Europe   (Belgium)

^j LA TOUR HOSPITAL   (Switzerland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ACUTE CORONARY SYNDROME; ADULT; ADVERSE OUTCOME; ARTICLE; CARDIAC PATIENT; CARDIOVASCULAR RISK; CHARLSON COMORBIDITY INDEX; CHRONIC KIDNEY DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONGESTIVE HEART FAILURE; CONNECTIVE TISSUE DISEASE; CORONARY STENT; CORONARY STENTING; COUNSELING; DEMENTIA; DIABETES MELLITUS; DRUG ELUTING CORONARY STENT; FEMALE; FOLLOW UP; HEART DEATH; HEART INFARCTION; HEMIPLEGIA; HUMAN; LEUKEMIA; LIVER DISEASE; LYMPHOMA; MALE; MIDDLE AGED; MORBIDITY; OUTCOME ASSESSMENT; PEPTIC ULCER; PERCUTANEOUS CORONARY INTERVENTION; PERIPHERAL VASCULAR DISEASE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SOLID TUMOR; ST SEGMENT ELEVATION; AGED; ANGIOCARDIOGRAPHY; ASIA; CEREBROVASCULAR DISORDERS; CLINICAL TRIAL; COMORBIDITY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DRUG ELUTING STENT; EUROPE; KAPLAN MEIER METHOD; MULTICENTER STUDY; PROGNOSIS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SURVIVAL RATE; TIME; TRENDS;

AGED; ASIA; CEREBROVASCULAR DISORDERS; COMORBIDITY; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DRUG-ELUTING STENTS; EUROPE; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; PREVALENCE; PROGNOSIS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SURVIVAL RATE; TIME FACTORS;

EID: 84937517368     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2015.04.047     Document Type: Article

References (28)

1. M.A. Velders, S.K. James, B. Libungan, G. Sarno, O. Frobert, J. Carlsson, M.J. Schalij, P. Albertsson, and B. Lagerqvist Prognosis of elderly patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention in 2001 to 2011: a report from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR) registry Am Heart J 167 2014 666 673
2. A. Lopez-de-Andres, R. Jimenez-Garcia, V. Hernandez-Barrera, N. Perez-Farinos, J.M. de Miguel-Yanes, M. Mendez-Bailon, I. Jimenez-Trujillo, A.G. de Miguel, C.G. Pino, and P. Carrasco-Garrido National trends in utilization and outcomes of coronary revascularization procedures among people with and without type 2 diabetes in Spain (2001-2011) Cardiovasc Diabetol 13 2014 3
3. K. Christensen, G. Doblhammer, R. Rau, and J.W. Vaupel Ageing populations: the challenges ahead Lancet 374 2009 1196 1208
4. K.R. Bainey, F. Selzer, H.A. Cohen, O.C. Marroquin, E.M. Holper, M.M. Graham, D.O. Williams, and D.P. Faxon Comparison of three age groups regarding safety and efficacy of drug-eluting stents (from the National Heart, Lung, and Blood Institute Dynamic Registry) Am J Cardiol 109 2012 195 201
5. D. Radovanovic, B. Seifert, P. Urban, F.R. Eberli, H. Rickli, O. Bertel, M.A. Puhan, P. Erne AMIS Plus Investigators Validity of Charlson Comorbidity Index in patients hospitalised with acute coronary syndrome. Insights from the nationwide AMIS Plus Registry 2002-2012 Heart 100 2014 288 294
6. M. Sachdev, J.L. Sun, A.A. Tsiatis, C.L. Nelson, D.B. Mark, and J.G. Jollis The prognostic importance of comorbidity for mortality in patients with stable coronary artery disease J Am Coll Cardiol 43 2004 576 582
7. L.B. Goldstein, G.P. Samsa, D.B. Matchar, and R.D. Horner Charlson Index comorbidity adjustment for ischemic stroke outcome studies Stroke 35 2004 1941 1945
8. F.J. Ruiz-Laiglesia, M. Sanchez-Marteles, J.I. Perez-Calvo, F. Formiga, J.A. Bartolome-Satue, A. Armengou-Arxe, R. Lopez-Quiros, J. Perez-Silvestre, A. Serrado-Iglesias, and M. Montero-Perez-Barquero Comorbidity in heart failure. Results of the Spanish RICA Registry QJM 107 2014 989 994
9. M.A. Mamas, S.G. Anderson, P.D. O'Kane, B. Keavney, J. Nolan, K.G. Oldroyd, D. Perera, S. Redwood, A. Zaman, P.F. Ludman, M.A. de Belder British Cardiovascular Intervention Society, The National Institute for Cardiovascular Outcomes Research Impact of left ventricular function in relation to procedural outcomes following percutaneous coronary intervention: insights from the British Cardiovascular Intervention Society Eur Heart J 35 2014 3004 3012
10. M.A. Mamas, K. Ratib, H. Routledge, L. Neyses, D.G. Fraser, M. de Belder, P.F. Ludman, J. Nolan British Cardiovascular Intervention Society, The National Institute for Cardiovascular Outcomes Research Influence of arterial access site selection on outcomes in primary percutaneous coronary intervention: are the results of randomized trials achievable in clinical practice? JACC Cardiovasc Interv 6 2013 698 706
11. M.A. Mamas, S.G. Anderson, K. Ratib, H. Routledge, L. Neyses, D.G. Fraser, I. Buchan, M.A. de Belder, P. Ludman, J. Nolan British Cardiovascular Intervention Society, National Institute for Cardiovascular Outcomes Research Arterial access site utilization in cardiogenic shock in the United Kingdom: is radial access feasible? Am Heart J 167 2014 900 908.e1
12. M.E. Charlson, P. Pompei, K.L. Ales, and C.R. MacKenzie A new method of classifying prognostic comorbidity in longitudinal studies: development and validation J Chronic Dis 40 1987 373 383
13. S.R. Erickson, E. Cole, E. Kline-Rogers, and K.A. Eagle The addition of the Charlson Comorbidity Index to the GRACE Risk Prediction Index improves prediction of outcomes in acute coronary syndrome Popul Health Manag 17 2014 54 59
14. J. Sanchis, J. Nunez, V. Bodi, E. Nunez, A. Garcia-Alvarez, C. Bonanad, A. Regueiro, X. Bosch, M. Heras, J. Sala, O. Bielsa, and A. Llacer Influence of comorbid conditions on one-year outcomes in non-ST-segment elevation acute coronary syndrome Mayo Clin Proc 86 2011 291 296
15. P.E. Jimenez Caballero, F. Lopez Espuela, J.C. Portilla Cuenca, J.M. Ramirez Moreno, J.D. Pedrera Zamorano, and I. Casado Naranjo Charlson comorbidity index in ischemic stroke and intracerebral hemorrhage as predictor of mortality and functional outcome after 6 months J Stroke Cerebrovasc Dis 22 2013 e214 e218
16. M. Singh, C.S. Rihal, R.J. Lennon, J.A. Spertus, K.S. Nair, and V.L. Roger Influence of frailty and health status on outcomes in patients with coronary disease undergoing percutaneous revascularization Circ Cardiovasc Qual Outcomes 4 2011 496 502
17. R. Jeger, M. Jaguszewski, B.N. Nallamothu, T.F. Luscher, P. Urban, G.B. Pedrazzini, P. Erne, D. Radovanovic, and A.P. Investigators Acute multivessel revascularization improves 1-year outcome in ST-elevation myocardial infarction: a nationwide study cohort from the AMIS plus registry Int J Cardiol 172 2014 76 81
18. G.B. Danzi, B. Chevalier, P. Urban, F. Fath-Ordoubadi, D. Carrie, M. Wiemer, A. Serra, W. Wijns, P. Kala, A. Stabile, J.G. Ruigomez, D. Sagic, P. Laanmets, G. Strupp, N. West, D. Paunovic NOBORI 2 Investigators Clinical performance of a drug-eluting stent with a biodegradable polymer in an unselected patient population: the NOBORI 2 study EuroIntervention 8 2012 109 116
19. F. Fath-Ordoubadi, E. Spaepen, M. El-Omar, D.G. Fraser, M.A. Khan, L. Neyses, G.B. Danzi, A. Roguin, D. Paunovic, and M.A. Mamas Outcomes in patients with acute and stable coronary syndromes; insights from the prospective NOBORI-2 study PLoS One 9 2014 e88577
20. F. Fath-Ordoubadi, Y. Barac, E. Abergel, G.B. Danzi, A. Kerner, E. Nikolsky, M. Halabi, M. Mamas, M. El-Omar, D. Fraser, and A. Roguin Gender impact on prognosis of acute coronary syndrome patients treated with drug-eluting stents Am J Cardiol 110 2012 636 642
21. G. Montalescot, H.D. White, R. Gallo, M. Cohen, P.G. Steg, P.E. Aylward, C. Bode, M. Chiariello, S.B. King III, R.A. Harrington, W.J. Desmet, C. Macaya, S.R. Steinhubl STEEPLE Investigators Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention N Engl J Med 355 2006 1006 1017
22. L. Mauri, W.H. Hsieh, J.M. Massaro, K.K. Ho, R. D'Agostino, and D.E. Cutlip Stent thrombosis in randomized clinical trials of drug-eluting stents N Engl J Med 356 2007 1020 1029
23. Z. Sargsyan, C. Higgins, S. Alexandrescu, D.A. Ott, and S.K. Jain Acute promyelocytic leukemia as a cause of intracoronary drug-eluting-stent thrombosis Tex Heart Inst J 39 2012 416 419
24. S. Tanaka, R. Sakata, A. Marui, Y. Furukawa, T. Kita, T. Kimura CREDO-Kyoto Investigators Predicting long-term mortality after first coronary revascularization: - the Kyoto model Circ J 76 2012 328 334
25. J.M. Brennan, J.P. Curtis, D. Dai, S. Fitzgerald, A.K. Khandelwal, J.A. Spertus, S.V. Rao, M. Singh, R.E. Shaw, K.K. Ho, R.J. Krone, W.S. Weintraub, W.D. Weaver, E.D. Peterson National Cardiovascular Data Registry Enhanced mortality risk prediction with a focus on high-risk percutaneous coronary intervention: results from 1,208,137 procedures in the NCDR (National Cardiovascular Data Registry) JACC Cardiovasc Interv 6 2013 790 799
26. S. Chowdhary, J. Ivanov, K. Mackie, P.H. Seidelin, and V. Dzavik The Toronto score for in-hospital mortality after percutaneous coronary interventions Am Heart J 157 2009 156 163
27. M. Singh, R.J. Lennon, D.R. Holmes Jr., M.R. Bell, and C.S. Rihal Correlates of procedural complications and a simple integer risk score for percutaneous coronary intervention J Am Coll Cardiol 40 2002 387 393
28. V. Farooq, Y. Vergouwe, L. Raber, P. Vranckx, H. Garcia-Garcia, R. Diletti, A.P. Kappetein, M.A. Morel, T. de Vries, M. Swart, M. Valgimigli, K.D. Dawkins, S. Windecker, E.W. Steyerberg, and P.W. Serruys Combined anatomical and clinical factors for the long-term risk stratification of patients undergoing percutaneous coronary intervention: the Logistic Clinical SYNTAX score Eur Heart J 33 2012 3098 3104